PVG.L Regulatory News (PVG)

1 Apr 2008 15:26

Ark Therapeutics Group PLC01 April 2008 ARK THERAPEUTICS GROUP PLC 1 April 2008 Annual Information Update Ark Therapeutics Group plc (the "Company") is pleased to provide an annualinformation update in accordance with the requirements of Prospectus Rule 5.2.This update refers to information that has been published or made available bythe Company to the public in the 12 months up to and including 31 March 2008. The following UK regulatory announcements have been made via the Regulatory NewsService provided by the London Stock Exchange: Date Headline 2 April 2007 Annual Information Update2 April 2007 Voting Rights and Capital24 April 2007 Research Update26 April 2007 Results of AGM27 April 2007 Regulatory Update30 April 2007 Voting Rights and Capital2 May 2007 Trinam RAC Application22 May 2007 Trinam Update31 May 2007 Research Update31 May 2007 Voting Rights and Capital7 June 2007 Kerraped Launch8 June 2007 Blocklisting Interim Review8 June 2007 Blocklisting Interim Review15 June 2007 Director's Share Dealing22 June 2007 Holding(s) in Company29 June 2007 Voting Rights and Capital6 July 2007 EPO Grant Stroke Patent23 July 2007 Re: Cerepro24 July 2007 Notice of Results26 July 2007 Research Update31 July 2007 Voting Rights and Capital20 August 2007 Re: Product Launch29 August 2007 Interim Results31 August 2007 Voting Rights and Capital28 September 2007 Voting Rights and Capital8 October 2007 Re: Agreement10 October 2007 Re: Agreement16 October 2007 Holding(s) in Company22 October 2007 Holding(s) in Company25 October 2007 Research Update31 October 2007 Holding(s) in Company6 November 2007 Placing and Open Offer28 November 2007 Re Placing and Open Offer29 November 2007 Result of EGM30 November 2007 Voting Rights and Capital30 November 2007 Director/PDMR Shareholding4 December 2007 Holding(s) in Company4 December 2007 Blocklisting Interim Review4 December 2007 Blocklisting Interim Review5 December 2007 Holding(s) in Company5 December 2007 Holding(s) in Company6 December 2007 Holding(s) in Company8 January 2008 Acquisition9 January 2008 Resignation of NED11 January 2008 Director/PDMR Shareholding17 January 2008 Employee Benefit Trust18 January 2008 Research Update23 January 2008 Notice of Results31 January 2008 Voting Rights and Capital13 February 2008 Manufacturing Update5 March 2008 Holdings in Company11 March 2008 Final Results11 March 2008 Launch of Neuropad20 March 2008 Board Appointment28 March 2008 Appointment31 March 2008 Voting Rights and Capital Copies of all regulatory announcements for Ark Therapeutics Group plc can befound on the Press Release Archive page on the Company's websitewww.arktherapeutics.com The Ark Therapeutics Group plc Annual Report 2007 and the Interim Report 2007were filed on 27 March 2008 and 5 September 2007 respectively at the UKLADocument Viewing Facility, Financial Services Authority, 25 The Colonnade,Canary Wharf, London E14 5HS. These documents are also available on theCompany's website www.arktherapeutics.com or on application to the CompanySecretary. A Placing and Open Offer prospectus was filed at the UKLA Document ViewingFacility, Financial Services Authority, 25 The Colonnade, Canary Wharf, LondonE14 5HS on 6 November 2007. This document is available upon application to theCompany Secretary. The Company has also made the following filings at Companies House: Date of Filing Document filed 23 April 2007 Return of Allotment of Shares26 April 2007 Resolutions passed at AGM3 May 2007 Return of Allotment of Shares14 May 2007 Return of Allotment of Shares11 June 2007 Return of Allotment of Shares25 June 2007 Return of Allotment of Shares31 July 2007 Return of Allotment of Shares7 August 2007 Return of Allotment of Shares5 September 2007 Return of Allotment of Shares5 September 2007 Return of Allotment of Shares21 September 2007 Return of Allotment of Shares28 September 2007 Return of Allotment of Shares19 November 2007 Annual Return30 November 2007 Notice of Increase in Nominal Capital30 November 2007 Resolution passed at EGM4 December 2007 Return of Allotment of Shares11 January 2008 Return of Allotment of Shares17 January 2008 Return of Allotment of Shares17 January 2008 Return of Allotment of Shares30 January 2008 Return of Allotment of Shares6 February 2008 Return of Allotment of Shares6 February 2008 Return of Allotment of Shares28 February 2008 Form 288b Terminating appointment of secretary28 February 2008 Form 288a Appointment of secretary Copies of these documents may be obtained from Companies House, Crown WayMaindy, Cardiff CF14 3UZ or through Companies House Direct atwww.direct.companieshouse.gov.uk. Further information is available regarding the Company and its activities on itswebsite www.arktherapeutics.com. The information referred to in this update was up to date at the time theinformation was published, but some information may now be out of date. Enquiries: Ark Therapeutics Group plc 020 7388 7722 Martyn Williams, Company Secretary This information is provided by RNS The company news service from the London Stock Exchange